This interactive CME activity focuses on the recognition and management of venous thromboembolism (VTE) in primary care. The program reviews risk factors for VTE, including provoked and unprovoked VTE; appropriate use of direct oral anticoagulants; and long-term care considerations, including safe transitions of care and medication adherence. Information is provided via three case vignettes, presented in order of increasing clinical difficulty.
Case studies with interactive benchmarking
After completing this activity, participants should be better able to:
- Describe risk factors for VTE and recurrent VTE in order to improve the recognition and diagnosis of VTE, including provoked and unprovoked VTE
- Identify appropriate treatment regimens for the management of VTE based on the safety and efficacy of direct oral anticoagulants (DOACs) and patient factors
- Devise protocols to coordinate specialty care, provide safe transitions, and improve patient adherence to long-term VTE therapy
NPs and PAs
CNE Credit Designation Statement
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing contact hours: 1.00, which includes 1.00 hours of pharmacology credit.
Nurse Planner: Mary Knudtson, DNSc, NP, FAAN
PA Planner: Daniel Thibodeau, MHP, PA-C
AAPA Credit Designation Statement
Continuing Education Alliance has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until March 5, 2020. PAs should only claim credit commensurate with the extent of their participation.
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from Bristol-Myers Squibb and Pfizer Alliance.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are required to disclose to the audience any significant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Tapson: consultant: Inari, Janssen; grant/research support: BiO2 Medical, BTG, Daiichi Sankyo, Inari, Janssen.
None of the members of the Planning Committee or CE Alliance staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Read the activity in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: March 5, 2019
Expiration date: March 5, 2020
© 2020 Practicing Clinicians Exchange. All Rights Reserved. BPCE95518